{
    "2019-04-08": [
        [
            {
                "time": "2019-04-08",
                "original_text": "After Hours Most Active for Apr 8, 2019: AMH, FOLD, AABA, PFE, BILI, QQQ, URBN, BAC, EMB, MRK, SCHW, NEM",
                "features": {
                    "keywords": [
                        "Most Active",
                        "PFE",
                        "MRK"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-08",
                "original_text": "Corcept (CORT) Rides High on Cushing's Syndrome Drug Korlym",
                "features": {
                    "keywords": [
                        "CORT",
                        "Cushing's Syndrome",
                        "Korlym"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-08",
                "original_text": "The Zacks Analyst Blog Highlights: Pfizer, Teva, Novartis, Merck and AstraZeneca",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Pfizer",
                        "Teva",
                        "Novartis",
                        "Merck",
                        "AstraZeneca"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-08",
                "original_text": "Health Care Sector Update for 04/08/2019: MDGL, CTST, QURE, JPM, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "MDGL",
                        "CTST",
                        "QURE",
                        "JPM",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}